These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6980443)

  • 21. Serum IgG, IgM, and IgA levels in ankylosing spondylitis.
    Veys EM; van Leare M
    Ann Rheum Dis; 1973 Nov; 32(6):493-6. PubMed ID: 4202498
    [No Abstract]   [Full Text] [Related]  

  • 22. Systemic and mucosal antibodies to Klebsiella in patients with ankylosing spondylitis and Crohn's disease.
    O'Mahony S; Anderson N; Nuki G; Ferguson A
    Ann Rheum Dis; 1992 Dec; 51(12):1296-300. PubMed ID: 1485810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunological aberrations in ankylosing spondylitis patients.
    Liu HC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1984 Feb; 17(1):19-24. PubMed ID: 6744992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C-reactive protein, ESR, and klebsiella in ankylosing spondylitis.
    Cowling P; Ebringer R; Cawdell D; Ishii M; Ebringer A
    Ann Rheum Dis; 1980 Feb; 39(1):45-9. PubMed ID: 7377858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunological reactivity in ankylosing spondylitis. Circulating immunoblasts, autoantibodies, and immunoglobulins.
    Eghtedari AA; Davis P; Bacon PA
    Ann Rheum Dis; 1976 Apr; 35(2):155-7. PubMed ID: 942271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating levels of Th1 and Th2 chemokines in patients with ankylosing spondylitis.
    Wang J; Zhao Q; Wang G; Yang C; Xu Y; Li Y; Yang P
    Cytokine; 2016 May; 81():10-4. PubMed ID: 26827189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased levels of serum IgA as IgA1 monomers in ankylosing spondylitis.
    Hocini H; Iscaki S; Benlahrache C; Vitalis L; Chevalier X; Larget-Piet B; Bouvet JP
    Ann Rheum Dis; 1992 Jun; 51(6):790-2. PubMed ID: 1616365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis.
    de Vries MK; van Eijk IC; van der Horst-Bruinsma IE; Peters MJ; Nurmohamed MT; Dijkmans BA; Hazenberg BP; Wolbink GJ
    Arthritis Rheum; 2009 Nov; 61(11):1484-90. PubMed ID: 19877087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppressors of cytokine signalling in ankylosing spondylitis and their associations with disease severity, acute-phase reactants and serum cytokines.
    Chen CH; Chen HA; Liao HT; Liu CH; Tsai CY; Chou CT
    Clin Exp Rheumatol; 2016; 34(1):100-5. PubMed ID: 26812031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cutaneous immunofluorescence in ankylosing spondylitis. Absence of correlation with disease activity.
    Peeters AJ; Boom BW; de Rooy-Dijk HH; Westedt ML; Breedveld FC
    J Rheumatol; 1990 Feb; 17(2):234-7. PubMed ID: 2181128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlative studies of lymphocyte transformation and plasma protein levels in ankylosing spondylitis.
    Kinsella TD
    J Rheumatol; 1979; 6(6):621-8. PubMed ID: 529247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoglobulin A and C reactive protein levels in ankylosing spondylitis.
    Collado A; Sanmarti R; Brancós MA; Kanterewicz E; Gallart T; Rotés-Querol J; Cobos A
    Ann Rheum Dis; 1987 Sep; 46(9):719-20. PubMed ID: 3675018
    [No Abstract]   [Full Text] [Related]  

  • 33. HLA-B27 and the immune response to enterobacterial antigens in ankylosing spondylitis.
    Trull A; Ebringer A; Panayi G; Ebringer R; James DC
    Clin Exp Immunol; 1984 Jan; 55(1):74-80. PubMed ID: 6607143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ig A antibodies to klebsiella in ankylosing spondylitis.
    Ardiçoğlu O; Atay MB; Ataoğlu H; Etiz N; Ozenci H
    Clin Rheumatol; 1996 Nov; 15(6):573-6. PubMed ID: 8973866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study.
    Kilic E; Kilic G; Akgul O; Ozgocmen S
    Rheumatol Int; 2015 Jun; 35(6):981-9. PubMed ID: 25366469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibodies to Klebsiella pneumoniae in Dutch patients with ankylosing spondylitis and acute anterior uveitis and to Proteus mirabilis in rheumatoid arthritis.
    Blankenberg-Sprenkels SH; Fielder M; Feltkamp TE; Tiwana H; Wilson C; Ebringer A
    J Rheumatol; 1998 Apr; 25(4):743-7. PubMed ID: 9558179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum secretory immunoglobulins in ankylosing spondylitis.
    Wendling D; Didier JM; Seilles E
    Clin Rheumatol; 1996 Nov; 15(6):590-3. PubMed ID: 8973869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural killer (NK) cell activity of peripheral blood lymphocytes from patients with Bechterew's syndrome (ankylosing spondylitis).
    Vinje O; Førre O; Degre M; Møller P
    Scand J Rheumatol; 1984; 13(4):297-302. PubMed ID: 6441246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The value of erythrocyte sedimentation rate and C-reactive protein in evaluating disease activity in ankylosing spondylitis].
    Liu B; Guo CY; Liu WQ; Wu N; Xing Q
    Zhonghua Nei Ke Za Zhi; 2005 Aug; 44(8):566-9. PubMed ID: 16194404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Higher frequency of peripheral blood follicular regulatory T cells in patients with new onset ankylosing spondylitis.
    Shan Y; Qi C; Zhao J; Liu Y; Gao H; Zhao D; Ding F; Wang J; Jiang Y
    Clin Exp Pharmacol Physiol; 2015 Feb; 42(2):154-61. PubMed ID: 25345823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.